Cannabis Law Report

DECEMBER 7, 2021

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52

DEA Patients Therapy Access 52

NORML

MARCH 1, 2019

Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” The agency said that the policy change was necessary because the existing system provided “no clear legal pathway for commercial enterprises to produce marijuana for product development.”

DEA 167

DEA Research and Development Clinical Trials Marijuana 167

WeedAdvisor

AUGUST 28, 2019

As we reported earlier , marijuana experts were frustrated over the poor quality of cannabis grown at the government’s only legal marijuana facility at the University of Mississippi. Despite a 90-day deadline for review, the DEA ignored this cut-off and simply sat on the applications for three years. Dozens of Applications”. .

DEA 61

DEA Marijuana History THC 61

Cannabis Law Report

JUNE 16, 2022

According to figures published in the DEA’s Domestic Cannabis Eradication/Suppression Program Statistical Report, agents and their partners confiscated approximately 5.53 million cultivated cannabis plants last year – a 20 percent increase over 2020’s totals. Federal law enforcement agents and their partners seized over 5.5

DEA 52

DEA Marijuana Programs Data 52

Cannabis Law Report

FEBRUARY 10, 2022

Court of Appeals for the Ninth Circuit dismissed a petition for review of a Drug Enforcement Administration (DEA) response to an attorney’s letter seeking advice and guidance on how a physician could administer psilocybin to a terminally ill patient without incurring liability under the Controlled Substances Act (CSA). By Allison Campbell.

DEA 52

DEA Clinical Trials Policy Research and Development 52

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. Lastly, the guide lays out the complex DEA registration process researchers much navigate to gain access to plants like psilocybin.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

JULY 7, 2021

Pennington, who focuses on federal appeals and regulatory issues, is co-counsel on several high-profile cases against the DEA regarding cannabis research, hemp, and psychedelics. The INCBA supports lawyers in their practice of law as they serve all aspects of the cannabis and related industries. Hemp Industries Association v.

DEA 111

DEA Hemp Cultivation Advocacy 111

Veriheal

SEPTEMBER 13, 2022

The legal cannabis industry in the United States has slowly expanded over the last decade. Despite the federal illegality of cannabis, lawmakers and state representatives have implemented successful medical and recreational cannabis programs across the nation. Homegrown Cannabis Statistics: Supplies, Growers and Products .

Cultivation 109

Cultivation Data DEA Dispensary 109

Veriheal

NOVEMBER 6, 2023

states and the District of Columbia currently have legal cannabis, medical or recreational. Despite this massive shift in cannabis policy, however, a few states are still dragging their feet on cannabis legalization. Idaho Idaho is one of the staunchest anti-cannabis states.

Legalization 117

Legalization Recreational THC CBD 117

Cannabis Law Report

OCTOBER 4, 2021

Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment. Access Pursuant to the Oregon Psilocybin Services Act. The shelter provided by this approach depends on the policy of the U.S. Source: [link].

Therapy 52

Therapy Patients Law Clinical Trials 52

Veriheal

NOVEMBER 11, 2023

Many states in the US have legalized cannabis, thirty-eight states to be exact. Despite the widespread adoption, the Food and Drug Administration still classifies cannabis as a Schedule One drug. Simply put, in the eyes of federal law, cannabis is illegal. Is Medical Cannabis Legal? allow the use of medical cannabis.

Law 62

Law Chronic Pain Conditions Legislation 62

SMPL

AUGUST 14, 2019

The American Bar Association (ABA) adopted a resolution on Monday that calls on Congress to allow states to set their own marijuana policies and recommends rescheduling or descheduling cannabis under federal law.

Policy 40

Policy Research and Development Marijuana DEA 40

Cannabis Law Report

AUGUST 12, 2022

Drug policy topics have become a consistent feature of the Austin-based event in recent years as more states have legalized cannabis and moved to reform laws around psychedelics like psilocybin locally and at the state level. Under the cannabis category, there are 61 options. Is cannabis actually. Green or not?

Research and Development 52

Research and Development Events Topical Policy 52

Cannabis Law Report

JULY 23, 2021

On Wednesday, July 14, 2021 Senators Chuck Schumer (D-NY), Cory Booker (D-NJ), and Ron Wyden (D-OR) released draft legislation titled the Cannabis Administration and Opportunity Act. If implemented, regulatory responsibility of cannabis would be transferred from the U.S. Draft Bill Details.

Research and Development 105

Research and Development DEA Programs State Laws 105

PrestoDoctor

JULY 16, 2019

Cannabis is just one case that represents the uphill battle it takes to overcome misinformation, fear, and even the hatred of groups of people, to gain sensible legislation. The gains created so far are largely credited to the work of cannabis reform groups. Prominent Cannabis Reform Groups in America and Beyond.

Policy 40

Policy DEA Access Media 40

PrestoDoctor

JULY 16, 2019

Cannabis is just one case that represents the uphill battle it takes to overcome misinformation, fear, and even the hatred of groups of people, to gain sensible legislation. The gains created so far are largely credited to the work of cannabis reform groups. Prominent Cannabis Reform Groups in America and Beyond.

Policy 40

Policy DEA Access Media 40

Cannabis Law Report

NOVEMBER 4, 2021

Should President Biden wish to acknowledge the political, economic, and moral realities surrounding cannabis policy, and fulfill the promises he made on the campaign trail, this report lays out a clear roadmap for how to do so.”. We’re beyond that.”. The FDA Director role continues to be unfilled.

DEA 52

DEA Marijuana Decriminalization Data 52

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. DEA and the Controlled Substances Act. In addition to the arduous FDA approval process, potential psychedelic therapies would also require complying with requirements from the Drug Enforcement Administration (DEA). Times (Nov.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Burns Levinson (Cannabusiness advisory)

OCTOBER 3, 2018

This marks the first time in history that the DEA has removed any type of cannabis from Schedule I, and clears the way for the sale of the first non-synthetic, cannabis-derived medicine to win federal approval. Therefore, it no longer meets the criteria for placement in Schedule I.

CBD 40

CBD DEA Epilepsy Pharmaceutical 40

Canna Law Blog

JULY 14, 2023

You can access the letters here. But, there’s a huge controversy about whether it can be controlled, with agencies like the DEA saying it is. FTC Policy Statement on Deception, 103 F.T.C. Ingesting edible cannabis products can result in serious health consequences in children.3 174, 176 n.9

Packaging 74

Packaging Food Edibles THC 74

Cannabis Law Report

JUNE 15, 2021

. – Today, ahead of the 50th anniversary—on June 17—of when President Richard Nixon declared the “war on drugs,” Representatives Bonnie Watson Coleman (D-NJ) and Cori Bush (D-MO) unveiled the Drug Policy Reform Act (DPRA), alongside the Drug Policy Alliance, which has been a strategic partner on the development of the legislation.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

CannaMD

SEPTEMBER 15, 2020

MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. The publicity surrounding this defeat helped to change the public attitude towards medical marijuana. ” Translation?

Law 126

Law Marijuana Patients Treatment 126

Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. The post Colorado Could Legalize Psychedelics This November appeared first on Cannabis Central. The Natural Medicine Health Act: Pros and Cons.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Veriheal

DECEMBER 27, 2022

Researchers have taken a big step in understanding the connection between using psychedelics and feeling connected to nature in a study published in the journal Drug Science, Policy, and Law on Oct. Study findings indicated that those who had previously taken LSD and psilocybin reported a greater sense of “nature relatedness.”

Research and Development 95

Research and Development Therapy Consumption DEA 95

NORML

APRIL 8, 2020

The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes.

Cultivation 352

Cultivation DEA Clinical Trials Marijuana 352

SpeedWeed

MARCH 18, 2021

Preliminary results from a long-awaited study indicate that cannabis appears to be a safe and well-tolerated treatment for patients managing post-traumatic stress disorder (PTSD), although researchers did not find strong signals of effectiveness. One group self-administered cannabis with 12% THC over three weeks.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Cannabis Law Report

JANUARY 13, 2022

In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. 1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. Maine Appeals Out-of-State Cannabis Dispensary Ruling. McGuireWoods LLP.

Dispensary 52

Dispensary Law Concentrates Patients 52

Canna Law Blog

JANUARY 11, 2022

The War on Cannabis continues through aggressive state and local enforcement and prohibition measures with no end in sight. The issue of enforcement or compliance is probably the biggest one most states face at the policy level. In 2019, there were reportedly 3,000 illegal cannabis businesses in California. The enforcement v.

Compliance 78

Compliance Compliance State Laws DEA 78

SpeedWeed

AUGUST 19, 2021

In recent months, a synthetic compound derived from hemp called THC-O acetate—often referred to simply as THC-O (pronounced “THC oh”)—has quickly gained popularity among Americans who don’t have access to legal cannabis. . THC-O products are increasingly popular in states where consumers don’t have access to legal cannabis.

THC 52

THC Hemp Extraction Vaping 52

Americans for Safe Access

AUGUST 31, 2023

What just Happened On Wednesday, Bloomberg news reported that Health and Human Services (HHS) is recommending that cannabis be rescheduled to Schedule III following the Food and Drug Administration’s (FDA) scientific review of cannabis under the direction of President Biden.

Policy 251

Policy DEA Food Cannabis 251

Cannabis Law Report

FEBRUARY 28, 2022

Importantly, control of psychedelics by a small number of companies may stifle innovation and reduce access to these therapies. 1669, 1670 (2021) (arguing that patents on psychedelics may limit research, innovation, and public access). Glenn Cohen, Psychedelic Therapy: A Roadmap for Wider Acceptance and Utilization , 27 NATURE MED.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

SEPTEMBER 1, 2021

FEDERAL TAXATION OF CANNABIS: A PRIMER. The manufacture, distribution, and possession of cannabis is illegal under federal law, which categorizes it as a Schedule 1 controlled substance. states have therefore, in one form or another, defied federal law with respect to cannabis use and distribution in their respective jurisdictions.

Policy 100

Policy Cannabis Treatment Law 100

Canna Law Blog

NOVEMBER 6, 2021

Despite overwhelming evidence that psilocybin is misclassified, this barrier restricts research, stifles competition and innovation, and inhibits access. But only if it is made affordable and accessible. Historically, attempts to reschedule cannabis through this pathway have failed. For two decades, U.S.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Veriheal

AUGUST 19, 2022

For several decades now, hemp, psilocybin, and cannabis products, in general, have been frowned upon by the federal government. But times are changing, and leaders are now calling for revamped policies on psilocybin, hemp, and cannabis research for varying reasons. Hemp Should Be Embraced as an Alternative to Plastics.

Hemp 52

Hemp DEA Access Cultivation 52

Cannabis Law Report

NOVEMBER 2, 2021

Delta-8 THC is making big waves in the cannabis industry at the minute, but with warnings from the FDA and CDC , not to mention harrowing accounts from users , it’s clear there’s more going on with the novel cannabinoid than meets the eye. And that was just the beginning. But it can’t really be as bad as it sounds, can it?

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

SEPTEMBER 23, 2019

of the global population uses cannabis annually, making it the most commonly used drug worldwide. During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. It should be noted that cannabis and marijuana are not interchangeable terms.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40